{"disease":{"id":"respiratory-papillomatosis","name":"respiratory papillomatosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03465280","title":"Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Newcastle-upon-Tyne Hospitals NHS Trust","has_results":false},{"nct_id":"NCT06000527","title":"Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort \" REPA \")","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Imagine Institute","has_results":false},{"nct_id":"NCT06412172","title":"The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07339163","title":"Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT04724980","title":"Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Precigen, Inc","has_results":false},{"nct_id":"NCT04398433","title":"INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT06538480","title":"Zopa Retreatment and Vector Shedding in Adults With RRP","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Precigen, Inc","has_results":false},{"nct_id":"NCT02859454","title":"Avelumab for People With Recurrent Respiratory Papillomatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03707587","title":"M7824 in People With Recurrent Respiratory Papillomatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}